source
- Latus Bio secures $42 million to launch Huntington’s disease gene therapy trialBiotech startup Latus Bio announced it has raised $42 million to fund its first clinical trials, including a gene‑therapy program aimed at Huntington’s disease. The capital will be used to seek FDA…
- New visa hurdles push foreign PhD scientists to abandon US labs for home-country jobsRecent data show a decline in applications from international students and researchers to U.S. labs, as new immigration procedures create uncertainty. The article follows a PhD candidate from Indi…